|Articles|October 12, 2020
Characterization of Viral Vector Particles Using the Agilent 6545XT AdvanceBio LC/Q-TOF
Author(s)Agilent Technologies
Workflow for the characterization of critical quality attributes (CQAs) of intact adeno-associated viruses (AAVs), together with identification of the capsid proteins.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Related Content
Trending on BioPharm International
1
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
2
Novel Delivery Approaches of Biopharmaceuticals 2025
3
EMA Director Highlights Agency Achievements in 2025
4
EU Clears Subcutaneous Biologic for Lupus, Advancing Patient-Controlled Delivery
5